category
PNAS
date
Feb 11, 2026
slug
status
Published
summary
通过基因工程改造巨核细胞使其在体内生成具有溶瘤特性的血小板,克服传统溶瘤病毒系统给药时的抗体介导限制,提升癌症免疫治疗效果。
tags
合成生物学
基因编辑
核酸蛋白工具酶
type
Post
📄 原文题目
Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy
🔗 原文链接
💡 AI 核心解读
通过基因工程改造巨核细胞使其在体内生成具有溶瘤特性的血小板,克服传统溶瘤病毒系统给药时的抗体介导限制,提升癌症免疫治疗效果。
📝 英文原版摘要
Proceedings of the National Academy of Sciences, Volume 123, Issue 7, February 2026. <br />SignificanceOncolytic viruses (OVs) are emerging as promising cancer therapeutics that selectively kill tumor cells and induce antitumor immunity. However, therapeutic effectiveness of OVs via systemic administration is limited by antibody-mediated ...
- 作者:NotionNext
- 链接:https://tangly1024.com/article/30c48bd6-1f96-816c-b83f-d445c4ad83fc
- 声明:本文采用 CC BY-NC-SA 4.0 许可协议,转载请注明出处。
相关文章
